Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-12

Clinical Trial Update: MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis

View source ↗

Summary

A completed clinical trial evaluating MINRIN desmopressin tablets and fast-dissolving forms for primary nocturnal enuresis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MINRIN (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturnal Enuresis | Status: COMPLETED